Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Find out MoreLondon South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://www.ft.com/content/5c45f23b-9b43-4a95-8dcc-44587317b0dd potentially welcome news for the macro environment.
Looks like we are starting to experience the beneficial effects of the interest rate turn.the monthly news letter for november is worth a quick read.
The buybacks continue apace.i assume that the benefit of these will only be fully experienced when(hopefully not if)the cycle turns and bios once again become in vogue perhaps when interest rates turn and finance becomes less of a problem.
Ah ah. i can see i was well behind the curve.didntrealise there had been news on friday eveninghttps://www.reuters.com/markets/deals/us-ftc-allows-amgen-move-forward-with-278-bln-horizon-deal-cnbc-2023-09-01/ perhaps an uptick on monday?
Https://www.biospace.com/article/ftc-s-challenge-to-amgen-horizon-merger-sparks-industry-attention/#:~:text=Amgen%27s%20acquisition%20of%20Horizon,Commission%20(FTC)%20in%20May. this presents an optimistic view of the likely outcome, but I've no idea how authoritative it is and whether ,for example, an appeal from the court's decision is possible,which would delay matters further. anyway, not long till october for news. im not overly familiar with the background to all this and apologies if there have been developments since june which may put a different perspective on matters. certainly one to keep an eye on .
Hopefully if this deal does come off then it will pull this up out of the doldrums.
Yes I know
My name is James Duncan, Postdoctoral Research Fellow in Chemical Biology and I for one have been burned by this. Holding until this is 30% higher but not adding more. Prefer metal miners instead
Order history since sale .
30/9/22 to 4/10/22 on at 938p must of failed .
first part of last week orders on for today's 940p .
Missed it apparently two Fridays ago 28/10/22 @ 927p ( 1.25% cheaper then today )
Surprised to buy these back today @ 940p approx 4% cheaper then the forced sale .
Good example of selling at a two week high when market in free fall.
This time last year a high of 1232p the low 753p on my birthday, volatile for a fund . lowest after forced sale was 29/10/22 @ 927p
Order history will not show maybe I tried to buy it then ?
Sold this on the Margin call that I could not fund 28/9/22 for 973p , in hindsight I did need to keep the bigger safety sum on margin .
The original idea was to buy on days like 28/9/22.
................................................................
Markets fell and pound crashed ( Guardian "meltdown " ) after Kwassi Kwarteng first mini budget five days ago on 23/9/22. ( 5 days before )
Spread 2% today 20p
incredible how no comments on this board when some have now come to buy- complete silence- the managers say the small and mid caps where he invests have been hammered unjustifiably vs big caps but sound confident that his will reverse but maybe not in the short term
Yo! Fellow holder here. Hoping it recovers the lost ground.
whewre is eveyone here
Any idea why ?
We're getting brayed like a donkey!
No!....
I was wrong about the Covid silver bullet (see 05-Aug post), it seems there's not just 1 but 2 or 3 (maybe more). That's brilliant news, and not so bad for BIOG as it can now fall-back on producing the goods for an ageing and increasingly wealthy population in the Western World.
good strong start to week
Probably a good sector to be in as Covid-19 seems to be having lasting effects on those aged 40+ who are affected - and they are going to need treatments long-term. Personally, my opinion is that there will not be a silver bullet for Covid-19 and so it's likely to be a risk for many years to come until the general population grow immune to it - which is going to take anything from 30 to 50 years. If you are under 40yo and can get health insurance, it could be a good idea as in 10 or 15 years (when may likely need it) the cost of obtaining insurance cover may be prohibitive if you are not already in the insurance system.
does this one still got got legs- any risks as it is on a premium?
2 months ago these were just above £7, have now risen steadily to £12.
More like the "No Hilary" effect.
Plus8% on the day at the time of writing. :)
Bio bought back over 2m GBP of own shares last Friday. Today carries news of 2 potential huge deals in this sector. I guess Bio feel their shares are undervalued. So do I!
The spread can really vary on this share and this makes it difficult to place a stop. They were sold for 5p lower than my stop so I feel robbed. I won't be buying these again, as it seems unpredictable at present.
My view is that if prices are limited, within reason, more people will have access to treatments, therefore I imagine it would enhance drug development. We don't slow down costly IT development because computer software is cheaper. We say 'everyone wants it now, what else could be developed'. The top 10 holdings here look pretty much oversold. The fundamentals are good i.e. PE ratios, eps growth and forecasts. I guess volatility is to be expected, but on the other hand biotech carries on regardless in a bearish market imo.